Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,081 public trials 1,850 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Completed

Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

NCT03490669

Conditions
Adnexal Diseases, Advanced Solid Tumors, Bronchial Neoplasms, +28 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • START MidWest Grand Rapids, Michigan, United States
  • Memorial Sloan Kettering Cancer Center- Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center- Westchester Harrison, New York, United States
View Trial Details
Completed

A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

NCT04148937

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +52 more
Locations
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Washington University Medical School St Louis, Missouri, United States
View Trial Details
Completed

A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib

NCT03076164

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +15 more
Locations
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

NCT04818983

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Hyogo Cancer Center Akashi, Japan
  • Asahikawa Medical University Hospital Asahikawa, Japan
  • National Hospital Organization Asahikawa Medical Center Asahikawa, Japan
  • Juntendo University Hospital Bunkyō City, Japan
View all 95 locations
View Trial Details
Completed

Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

NCT04501497

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Akashi Medical Center Akashi, Japan
  • Hyogo Cancer Center Akashi, Japan
  • Hyogo Prefectural Amagasaki General Medical Center Amagasaki, Japan
  • Asahikawa Medical University Hospital Asahikawa, Japan
View all 148 locations
View Trial Details

Related conditions